Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/18/1992 | EP0475206A2 Angiotensin II receptor antagonists |
03/18/1992 | EP0475204A2 Heteroazepinoid amides |
03/18/1992 | EP0475187A1 Naphthothiophenimines for treating neuronal disorders caused by ischemia |
03/18/1992 | EP0475178A1 Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation |
03/18/1992 | EP0475156A1 Substituted 3-aminosydnonimines, method for their preparation and their use |
03/18/1992 | EP0475150A1 Antibiotic C-3 di-hydroxyphenyl substituted cephalosporin compounds, compositions and use thereof |
03/18/1992 | EP0475148A1 Pravastatin alone or in combination with a fibric acid derivative for preventing onset of or treating type III hyperlipoproteinemia |
03/18/1992 | EP0475071A1 2-acyloxy-4-morpholinyl anthracycline |
03/18/1992 | EP0474874A1 Maillard Reaction inhibitor compositions |
03/18/1992 | EP0474733A1 Antihyperlipidemic and antiatherosclerotic urea compounds. |
03/18/1992 | EP0474712A1 Lysolecithin derivatives for treating autoimmune diseases. |
03/18/1992 | EP0450080A4 Composition for the treatment of progressive myopia |
03/18/1992 | EP0380584B1 Polyene macrolide pre-liposomal powders |
03/18/1992 | EP0379500B1 Dermatological liposome composition containing pregnenolone |
03/18/1992 | EP0316364B1 Compositions for treating alopecia |
03/18/1992 | EP0266349B1 Tricyclic indole derivatives, their manufacture and use as medicines |
03/18/1992 | EP0259353B1 Use of cobalt proto - and/or mesoporphyrin for the production of a medicament for suppressing the endocrine system. |
03/18/1992 | EP0243369B1 9-halogen prostaglandine clathrates and utilization thereof as drugs |
03/18/1992 | EP0224504B1 Composition and method for reducing wrinkles |
03/18/1992 | EP0198901B1 Method for preparing 1alpha-hydroxyvitamin d compounds |
03/18/1992 | EP0188573B1 Dietary supplement for minimizing effects of infection |
03/18/1992 | CN1059529A Antiandrogen (3,2-c) pyrazole and (3,2-d)-triazole-steroid |
03/18/1992 | CN1059528A Carbocyclic analogs of certain nucleosides |
03/18/1992 | CN1059527A 6,7-substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid-0 3,0 4, bis(acyloxy-o) borate |
03/18/1992 | CN1059526A Synthesis of 4-sulpho-4-deoxidation-4'-demethyl podophyllotoxin derivative |
03/18/1992 | CN1059522A Stabilization and recovery method for to cotrienol and to copherol products |
03/18/1992 | CN1059521A Process and intermediate for preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids |
03/18/1992 | CN1059519A Sulfoamide derivatives |
03/18/1992 | CN1059517A Acetamide derivatives |
03/18/1992 | CN1059468A Ointments containing tricyclic compound |
03/18/1992 | CN1015893B 1,3-dioxanes |
03/18/1992 | CN1015892B Process for preparing a new derivative of an aminoketone |
03/18/1992 | CN1015872B Method of preparing injection for whole prolapse haemorrhoids |
03/18/1992 | CN1015871B Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-dihydro-4-oxo-7-(1-piperazinyl)-quinoling-3-carboxylic acid |
03/18/1992 | CA2091688A1 Antiproliferative substituted naphthalene compounds |
03/18/1992 | CA2091685A1 1-substituted phenoxathiin derivatives as antidepressants |
03/18/1992 | CA2090857A1 5-trifluoroacylamino-2-aryloxazoles 2-aryl-5-trifluoroacylaminooxazoles |
03/18/1992 | CA2051455A1 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
03/18/1992 | CA2050823A1 Fungicidal compositions and method |
03/18/1992 | CA2050043A1 Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
03/18/1992 | CA2050042A1 Method for preventing or treating anxiety employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
03/18/1992 | CA2049506A1 Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
03/17/1992 | US5097064 By reduction of arylacrylic acid using a rhodium derivative and water soluble chiral ligand as catalyst |
03/17/1992 | US5097059 Resolution process of intermediates useful for the preparation of diltiazem |
03/17/1992 | US5097042 Water-soluble benzimidazolotriazole derivative or salt thereof |
03/17/1992 | US5097023 α-glucosidase inhibitors |
03/17/1992 | US5096930 Preparation of the improvement of the regenerative process of injured striated muscles |
03/17/1992 | US5096929 Inotropic agents; vasodilation |
03/17/1992 | US5096927 Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds |
03/17/1992 | US5096926 Injectable formulations containing the sodium salt of naproxen |
03/17/1992 | US5096925 Enkephalinase enzyme inhibitor analgesics, hypotensive agents |
03/17/1992 | US5096924 Antitumor agent; isochromene derivative |
03/17/1992 | US5096922 Sorangicin antibiotics |
03/17/1992 | US5096921 Organic compounds |
03/17/1992 | US5096920 Liver disorders |
03/17/1992 | US5096918 Aldose reductase inhibitors, diabetes, galactosemia |
03/17/1992 | US5096917 Substituted indoles |
03/17/1992 | US5096916 Administering tolazoline |
03/17/1992 | US5096914 Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds |
03/17/1992 | US5096911 Alteration of rate and character of hair growth |
03/17/1992 | US5096908 Method of inhibiting gastric acid secretion |
03/17/1992 | US5096906 Method of inhibiting the activity of leukocyte derived cytokines |
03/17/1992 | US5096905 Basic cleavage products of elaiophylin and elaiophylin derivatives and use thereof |
03/17/1992 | US5096902 Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical compositions containing them and process for preparing same |
03/17/1992 | US5096901 Pharmacologically active amides and esters containing an azabicycloalkane moiety |
03/17/1992 | US5096899 Oxapenem-3-carboxylic acids |
03/17/1992 | US5096898 Bile acid unsaturated derivatives and pharmaceutical compositions containing them |
03/17/1992 | US5096897 Antithrombotic substituted cycloalkano(b)dihydroindole- and -indole-sulphonamides |
03/17/1992 | US5096894 For acute diarrhea |
03/17/1992 | US5096892 Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin |
03/17/1992 | US5096890 Pyrrolidine derivatives |
03/17/1992 | US5096889 Antimycotic compositions of nikkomycin compounds and azole antimycotics |
03/17/1992 | US5096888 Macrolactone antibiotics |
03/17/1992 | US5096887 Administering coumarin, rutin or troxerutin |
03/17/1992 | US5096884 Glidobactin pf-1 peptide antibiotics |
03/17/1992 | US5096717 Double-coated granules of disodium pamidronate |
03/17/1992 | US5096716 Dosage form for administering calcium antagonist nicardipine |
03/17/1992 | US5096715 Containing a fixed dosage, a vehicle and permeation enhancer |
03/17/1992 | US5096714 Prolonged release drug tablet formulations |
03/17/1992 | US5096713 Retinoic esters of l-cladinose, process for their preparation and their use in human of veterinary medicine and in cosmetic compositions |
03/17/1992 | US5096712 Administering tyrosine and synergistic indirect-acting sympathomimetic drug |
03/17/1992 | US5096708 Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides |
03/17/1992 | US5096703 Administering aminoguanidine or its salts; oral rinse, tooth paste |
03/17/1992 | US5096607 Using an aqueous system of a microbiocide of polyquaternized ammonium salts or biguanides and a proteolytic enzyme wherein the osmotic value is adjusted |
03/17/1992 | CA1297632C Organic compounds and their pharmaceutical use |
03/17/1992 | CA1297631C Ureido renin inhibitors |
03/17/1992 | CA1297492C Antagonists of specific excitatory amino acid neurotransmitter receptors |
03/17/1992 | CA1297478C 2,6-dideoxy-2-fluoro-l-talopyranose and derivatives thereof and the production of these compounds |
03/17/1992 | CA1297474C Process for preparing alkoxyalkylidenehydrazinopyridazine derivatives |
03/17/1992 | CA1297473C Crystallized cephem-acid addition salts, and a process for the preparation thereof |
03/17/1992 | CA1297472C 11-aryloestrane and 11-arylpregnane derivatives |
03/17/1992 | CA1297410C Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
03/17/1992 | CA1297408C Bioadhesive extruded film for intra-oral drug delivery and process |
03/17/1992 | CA1297368C Pulsed drug delivery |
03/15/1992 | WO1992004905A1 Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels |
03/15/1992 | CA2092722A1 Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosa-trienoic acid levels |
03/15/1992 | CA2051229A1 Hypocholesterolemic unsymmetrical dithiol ketals |
03/15/1992 | CA2051007A1 Naphthothiophenimines for treating neuronal disorders caused by ischemia |
03/15/1992 | CA2050634A1 Use of branched chain amino acids to effect diaphragm contractility and fatigue |
03/15/1992 | CA2050514A1 Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia |